1. Calcium influx and calpain activation: Neuronal activity leads to an influx of calcium ions (Ca2+) into neurons. High levels of Ca2+ activate calpain, a calcium-dependent protease. Calpain can cleave APP, generating smaller fragments, including amyloid-beta (Aβ), which is the primary component of amyloid plaques in Alzheimer's disease.
2. Activation of protein kinases: Neuronal activity also triggers the activation of various protein kinases, such as mitogen-activated protein kinase (MAPK) and cyclin-dependent kinase 5 (CDK5). These kinases phosphorylate APP and other proteins involved in APP processing, influencing APP cleavage and Aβ production.
3. Regulation of BACE1 activity: Beta-site APP-cleaving enzyme 1 (BACE1) is a key enzyme that initiates the cleavage of APP, leading to the production of Aβ. Neuronal activity can modulate BACE1 activity through various mechanisms, including the activation of protein kinases and changes in gene expression.
4. Synaptic activity and APP metabolism: Synaptic activity, which involves the communication between neurons, affects APP metabolism. High levels of synaptic activity can increase APP expression and processing, while low levels may decrease APP cleavage and Aβ production.
5. Neurotransmitter involvement: Neurotransmitters, the chemical messengers that facilitate communication between neurons, are also implicated in APP cleavage. For example, glutamate, the primary excitatory neurotransmitter in the brain, can increase APP cleavage and Aβ production through the activation of NMDA receptors.
It's important to note that the exact mechanisms linking neuronal activity to APP cleavage and Alzheimer's protein production are still not fully understood and remain an active area of research. Additionally, while neuronal activity can contribute to Alzheimer's disease pathology, it is likely a complex interplay of genetic, environmental, and aging factors that ultimately leads to the development and progression of the disease.
